In a first-in-human phase 1 trial in 41 patients with recurrent glioblastoma, an oncolytic virus treatment designed by Brigham researchers extended survival, especially among those … Continue reading Breaking Brain Cancer Barriers: New Gene Therapy Effectively Targets Glioblastoma